These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12204622)

  • 1. The self-association of the drug acemetacin and its interactions and stabilization with beta-cyclodextrin in aqueous solution as inferred from NMR spectroscopy and HPLC studies.
    Zouvelekis D; Yannakopoulou K; Mavridis IM; Antoniadou-Vyza E
    Carbohydr Res; 2002 Sep; 337(15):1387-95. PubMed ID: 12204622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of solution state complexation in wet-granulated oven-dried ibuprofen and beta-cyclodextrin: FT-IR and 1H-NMR studies.
    Ghorab MK; Adeyeye MC
    Pharm Dev Technol; 2001 Aug; 6(3):315-24. PubMed ID: 11485173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
    Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
    Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
    Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
    Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acemetacin monohydrate.
    Gelbrich T; Haddow MF; Griesser UJ
    Acta Crystallogr C; 2007 Aug; 63(Pt 8):o451-3. PubMed ID: 17675694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexation study of diclofenac with beta-cyclodextrin and spectrofluorimetric determination.
    Arancibia JA; Escandar GM
    Analyst; 1999 Dec; 124(12):1833-8. PubMed ID: 10746311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclodextrin derivatives on indomethacin stability in aqueous solution.
    Backensfeld T; Müller BW; Wiese M; Seydel JK
    Pharm Res; 1990 May; 7(5):484-90. PubMed ID: 2367316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical and biological properties of 6(1),6(3),6(5)-tri-O-alpha-maltosyl-cyclomaltoheptaose (6(1),6(3),6(5)-tri-O-alpha-maltosyl-beta-cyclodextrin).
    Okada Y; Semma M; Ichikawa A
    Carbohydr Res; 2007 Jul; 342(10):1315-22. PubMed ID: 17498674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular structures of the inclusion complexes beta-cyclodextrin-1,2-bis(4-aminophenyl)ethane and beta-cyclodextrin-4,4'-diaminobiphenyl; packing of dimeric beta-cyclodextrin inclusion complexes.
    Giastas P; Yannakopoulou K; Mavridis IM
    Acta Crystallogr B; 2003 Apr; 59(Pt 2):287-99. PubMed ID: 12657820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound.
    Redenti E; Zanol M; Ventura P; Fronza G; Comotti A; Taddei P; Bertoluzza A
    Biospectroscopy; 1999; 5(4):243-51. PubMed ID: 10478955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of p-hydroxybenzoic esters with beta-cyclodextrin.
    Chan LW; Kurup TR; Muthaiah A; Thenmozhiyal JC
    Int J Pharm; 2000 Feb; 195(1-2):71-9. PubMed ID: 10675685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13)C NMR spectrometry, and molecular dynamics simulation.
    Aki H; Niiya T; Iwase Y; Yamamoto M
    J Pharm Sci; 2001 Aug; 90(8):1186-97. PubMed ID: 11536223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclodextrin additives on azithromycin in aqueous solution and insight into the stabilization mechanism by sulfobutyl ether-β-cyclodextrin.
    Saita MG; Aleo D; Melilli B; Patti A
    Int J Pharm; 2019 Jul; 566():674-679. PubMed ID: 31202899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 1H NMR Study of Host/Guest Supramolecular Complexes of a Curcumin Analogue with β-Cyclodextrin and a β-Cyclodextrin-Conjugated Gemini Surfactant.
    Poorghorban M; Karoyo AH; Grochulski P; Verrall RE; Wilson LD; Badea I
    Mol Pharm; 2015 Aug; 12(8):2993-3006. PubMed ID: 26083126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution.
    Sigurjónsdóttir JF; Loftsson T; Másson M
    Int J Pharm; 1999 Sep; 186(2):205-13. PubMed ID: 10486439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complexes of nabumetone with beta-cyclodextrins: thermodynamics and molecular modelling studies. Influence of sodium perchlorate.
    Goyenechea N; Sánchez M; Vélaz I; Martín C; Martínez-Ohárriz MC; González-Gaitano G
    Luminescence; 2001; 16(2):117-27. PubMed ID: 11312537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of indomethacin eye drops via complexation with cyclodextrins.
    Halim Mohamed MA; Mahmoud AA
    Curr Eye Res; 2011 Mar; 36(3):208-16. PubMed ID: 21275515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of sodium salicylate by beta-cyclodextrin or 2,6-di-O-methyl-beta-cyclodextrin in aqueous solution.
    Junquera E; Peña L; Aicart E
    J Pharm Sci; 1998 Jan; 87(1):86-90. PubMed ID: 9452974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the pharmacodynamics of acemetacin (author's transl)].
    Jacobi H; Dell HD
    Arzneimittelforschung; 1980; 30(8A):1348-62. PubMed ID: 6968219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melarsoprol-cyclodextrins inclusion complexes.
    Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
    Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.